Editing Ranbaxy Laboratories (section)

=== Acquisition by Sun Pharmaceutical ===

On 7 April 2014, India-based [[Sun Pharmaceutical]] and Japan-based Daiichi Sankyo jointly announced the sale of the entire 63.4% share of Ranbaxy from [[Daiichi Sankyo]] to Sun Pharmaceutical in a $4 billion all-share deal. Under these agreements, shareholders of Ranbaxy were to receive a 0.8 share of Sun Pharmaceutical for each share of Ranbaxy.<ref name="bp">{{cite web|title=Sun Pharma to acquire Ranbaxy for $4 billion in all-share deal|url=http://news.biharprabha.com/2014/04/sun-pharma-to-acquire-ranbaxy-for-4-billion-in-all-share-deal/|agency=Indo-Asian News Service|publisher=news.biharprabha.com|access-date=7 April 2014}}</ref> After this acquisition, the partner [[Daiichi-Sankyo]] was to hold a stake of 9% in Sun Pharmaceutical.<ref>{{cite web|url=https://www.bloomberg.com/news/2014-04-06/sun-pharmaceuticals-to-buy-india-s-ranbaxy-in-4-billion-deal.html|title=India's Sun Pharma to Buy Ranbaxy in $4 Billion Deal|website=[[Bloomberg News]]|access-date=2014-04-06}}</ref>